Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway

Molecular Nutrition and Food Research

Volumn 59, Issue 3, 2015, Pages 443-453

  Nash, Leslie A ^a   Sullivan, Philip J ^a   Peters, Sandra J ^a   Ward, Wendy E ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

Flavonoid; Luteolin; Mineral; Orientin; Osteoblast; Rooibos

Indexed keywords

ANIMALIA; ASPALATHUS LINEARIS;

4-NITROPHENOL; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; FLAVONOID; GENETIC MARKER; GLUCOSIDE; LUTEOLIN; NITROPHENOL; ORIENTIN; OSTEOPONTIN; OSTEOPROTEGERIN; SOST PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ASPALATHUS; BONE MINERALIZATION; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENETIC MARKER; HUMAN; METABOLISM; MITOCHONDRION; OSTEOBLAST; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ALKALINE PHOSPHATASE; ASPALATHUS; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELL LINE; FLAVONOIDS; GENETIC MARKERS; GLUCOSIDES; HUMANS; LUTEOLIN; MITOCHONDRIA; NITROPHENOLS; OSTEOBLASTS; OSTEOPONTIN; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR-ALPHA; WNT SIGNALING PATHWAY;

EID: 84924001343     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400592     Document Type: Article

References (62)

1. Weaver, C.-M., Alkel, D.-L., Ward, W.-E., Ronis, M.-J., Flavonoid intake and bone health. J. Nutr. Gerontol. Geriatr. 2012, 31, 239-253.
2. Ward, W.-E., Kaludjerovic, J., Lau, B., Sacco, S.-M., in: Smith, J., Charter, E. (Eds.), Functional Food Development. Functional Food and Science & Technology Series, F. Shahidi (Ed.), Wiley-Blackwell, Oxford, UK 2010, pp. 459-503.
3. Johnston, C.-C., Slemenda, C.-W., Peak bone mass, bone loss and risk of fracture. Osteoporosis Int. 1994, 1, S43-S45.
4. Zallone, A., Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. NY. Acad. Sci. 2006, 1068, 173-179.
5. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N. et al., Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 2000, 191, 275-286.
6. Roux, S., Orcel, P., Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res. 2000, 2, 451-456.
7. Desai, M., Khatkhatay, M.-I., Taskar, V., Ansari, Z., Changes in cytokines, biomarkers of bone turnover and hormones are associated with bone loss in postmenopausal Indian women. Int. Endocrinol. Metab. 2012, 10, 399-403.
8. Rachon, D., Mysliwska, J., Suchecka-Rachon, K., Wiekiewicz, J., Mysliwski, A., Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J. Endocrinol. 2002, 172, 387-396.
9. Burge, R., Dawson-Hughes, B., Solomon, D.-H., Wong, J.-B. et al., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J. Bone Miner. Res. 2007, 22, 465-475.
10. Marinangeli, C.-P., Jones, P.-J., Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional foods and nutraceutical marketplace. Nutr. Res. Rev. 2013, 26, 12-21.
11. Johnell, O., Gullberg, B., Kanis, J.-A., Allander, E. et al., Risk factors for hip fracture in European women: the MEDOS study. Mediterranean Osteoporosis Study. J. Bone Miner. Res. 1995, 10, 1802-1815.
12. Keramat, A., Patwardhan, B., Larijani, B., Chopra, A. et al., The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskel. Dis. 2008, 9, 28.
13. Joubert, E., Beelders, T., de Beer, D., Malherbe, C.-J. et al., Variation in phenolic content and antioxidant activity of fermented rooibos tea infusions: Role of production season and quality grade. J. Agric. Food Chem. 2012, 60, 9171-9179.
14. Gadow, A.-V., Joubert, E., Hansmann, C.-F., Comparisons of the antioxidant activity of rooibos tea (Aspalathus linearis) with green, oolong and black tea. Food Chem. 1997, 60, 73-77.
15. Nel, E., Binns, T., Bek, D., Tourism as a local development strategy in South Africa. The Geographical J. 2007, 27, 112-129.
16. Joubert, E., de Beer, D., Rooibos (Aspalathus linearis) beyond the farm gate: from herbal tea to potential phytopharmaceutical. S. Afr. J. Bot. 2011, 77, 869-886.
17. Hallstrom, H., Wolk, A., Glynn, A., Michaelsson, K., Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporosis Int. 2006, 17, 1055-1064.
18. Rapuri, P.-B., Gallagher, J.-C., Kinyamu, H.-K., Ryschon, K.-L., Caffeine intake increase the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am. J. Clin. Nutr. 2001, 74, 694-700.
19. Harris, S.-S., Dawson-Hughes, B., Caffeine and bone loss in healthy postmenopausal women. Am. J. Clin. Nutr. 1994; 60, 573-580.
20. Bramati, L., Aquilano, F., Pietta, P., Unfermented rooibos tea: quantitative characterization of flavonoids by HPLC-UV and determination of the total antioxidant activity. J. Agric. Food Chem. 2003, 51, 7472-7474.
21. Koeppen, B.-H., Roux, D.-G., C-Glycosylflavonoids: the chemistry of aspalathin. Biochem J. 1966, 99, 604-609.
22. Stanford, C, -M., Jacobson, P.-A., Eanes, E.-D., Lembke, L.-A., Midura, R.-J., Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 1995, 270, 9420-9428.
23. Rao, L.-G., Kung-Sutherland, M.-S., Wylie, J.-N., Muzzafar, S.-A. et al., Positive interaction between 17β-estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone. Osteoporosis Int. 1996, 6, 111-119.
24. Wang, P., Henning, S.-M., Heber, D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One. 2010, 5, e10202.
25. Mosmann, T., Rapid colormetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
26. Choi, E.-M., Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3-E1 cells. Cell. Biol. Int. 2007, 21, 870-877.
27. Crasto, G.-J., Kartner, N., Yao, Y., Li, K. et al., Luteolin inhibition of V-ATPase A3-D2 interaction decreases osteoclast resorption activity. J. Cell Biochem. 2013, 114, 929-941.
28. Gadow, A., Joubert, E., Hansmann, C.-F., Comparison of the antioxidant activity of aspalathin with that of other plant phenols of rooibos tea (Aspalathus linearis), a-tocopherol, BHT, and BHA. J. Agric. Food Chem. 1997, 45, 632-638.
29. Uma, D.-P., Ganasoundari, A., Vrinda, B., Srinivasan, K.-K., Unnikrishnan, M.-K., Radiation protection by the ocimum flavonoids orientin and vicenin: mechanisms of action. Radiat. Res. 2000, 154, 455-460.
30. Wattel, A., Kamel, S., Mentaverri, R., Lorget, F. et al., Potent inhibitory effect of naturally occurring flavonoids quercetin and kaemferol on in vitro osteoclastic bone resorption. Biochem. Pharmacol. 2003, 65, 35-42.
31. Prouillet, C., Maziere, J., Maziere, C., Wattel, A. et al., Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol. 2004, 67, 1307-1313.
32. Yin, X., Chen, Z., Liu, Z., Ma, Q., Dang, G., Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 2. Chin. Med. J. (Engl.) 2007, 120, 204-210.
33. Khansari, N., Shakiba, Y., Mahmoudi, M., Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73-80.
34. Weber, C., Erl, W., Pietsch, A., Strobel, M. et al., Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 1994, 14, 1665-1673.
35. Jagger, C.-J., Lean, J.-M., Davis, J.-T., Chambers, T.-J., Tumor necrosis factor-α mediates osteopenia caused by depletion of antioxidants. Endocrinology 2005, 146, 113-118.
36. Benedetto, A.-D., Gigante, I., Colucci, S., Grano, M., Periodontal disease: linking the primary inflammation to bone loss. Clin. Dev. Immunol. 2013, 2013, 503754.
37. Schett, G., Gravallese, E., Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol. 2012, 8, 656-664.
38. Kimble, R.-B., Matayoshi, A.-B., Vannice, J.-L., Kung, V.-T. et al., Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995, 136, 3054-3061.
39. Assuma, R., Oates, T., Cochran, D., Amar, S., Graves, D.-T, IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 1998, 160, 403-409.
40. Stein, B., Yang, M.-X., Repression of the interleukin-6 promoter region by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol. Cell. Biol. 1995, 15, 4971-4979.
41. Glantschnig, H., Fisher, J.-E., Wesolowski, G., Rodan, G.-A., Reszka, A.-A., M-CSF, TNFα and rank ligand promote osteoclast survival through MTOR/S6. Cell Death Differ. 2003, 10, 1165-1177.
42. Gilbert, L., He, X., Farmer, P., Boden, S. et al., Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology, 2000, 141, 3956-3964.
43. Peruzzi, B., Cappariello, A., Del Fattore, A., Rucci, N. et al., C-SRC and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signaling. Nat. Commun. 2012, 13, 630.
44. Baba, H., Ohtsuka, Y., Haruna, H., Lee, T. et al., Studies of anti-inflammatory effects of rooibos tea in rats. Pediatr. Int. 2009, 51, 700-704.
45. Xie, C., Kang, J., Li, Z., Schauss, A.-G. et al., The acai flavonoid velutin is a potent anti-inflammatory agent: blockage of LPS-mediated TNF-a and IL-6 production through inhibiting NF-KB activation and MAPK pathway. J. Nutr. Biochem. 2012, 23, 1184-1191.
46. Fogh, J., Trempe, G., in: Fogh, J. (Ed.), Human Tumor Cells in Vitro, Plenum Press, New York and London 1975, pp. 115-159.
47. Miyashita, T., Kawakami, A., Nakashima, T., Yamasaki, S. et al., Osteoprotegerin (OPG) acts as an endrogenous decoy receptor in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Clin. Exp. Immunol. 2004, 137, 430-436.
48. Patino-Garcia, A., Zalacain, M., Folio, C., Zandueta, C. et al., Profiling of chemonaive osteosarcoma and paired-normal cells identified EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Clin. Cancer Res. 2009, 15, 5082-5091.
49. Brandstrom, H., Jonsson, K.-B., Vidal, O., Ljunghall, S. et al., Tumor necrosis factor-α and -β upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. Biochem. Biophys. Res. Commun. 1998, 248, 454-457.
50. Standal, T., Borset, M., Sundan, A., Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp. Oncol. 2004, 26, 179-184.
51. Boudin, E., Fijalkowski, I., Piters, E., Van Hul, W., The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Sem. in Arthritis Rheum. 2013, 43, 220-240.
52. Trzeciakiewicz, A., Habauzit, V., Mercier, S., Lebecque, P. et al., Hesperetin stimulates differentiation of primary rat osteoblasts involving BMP signaling pathway. J. Nutr. Biochem. 2010, 21, 424-431.
53. Cheng, S.-L., Zhang, S.-F., Nelson, T.-L., Warlow, P.-M., Civitelli, R., Stimulation of human osteoblast and function by ipriflavone and its metabolites. Calcif. Tissue. Int., 1994, 55, 356-362.
54. Watjen, W., Michels, G., Steffan, B., Niering, P. et al., Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J. Nutr. 2005, 135, 525-531.
55. Igile, G.-O., Oleszek, W., Jurzysta, M., Burda, S., Fafunso, M., Fasanmade, A.-A. Flavonoids from Vernonia amygdalina and their antioxidant activities. J. Agric. Food Chem. 1994, 42, 2445-2448.
56. Cao, G., Sofic, E., Prior, R.-L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 1997, 22, 749-760.
57. Breiter, T., Laue, C., Kressel, G., Groll, S. et al., Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations. Food Chem. 2011, 128, 338-347.
58. Wittemer, S.-M., Ploch, M., Windeck, T., Muller, S.-C. et al., Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomedicine 2005, 12, 28-38.
59. Shimoi, K., Okada, H., Furugori, M., Goda, T. et al., Intestinal absorption of luteolin and luteolin 7-O-β-glucoside in rats and humans. FEBS Lett. 1998, 438, 220-224.
60. Neveu, V., Perez-Jiménez, J., Vos, F., Crespy, V. et al., Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford), 2010.
61. Rothwell, J.-A., Urpi-Sarda, M., Boto-Ordonez, M., Knox, C. et al., Phenol-explorer 2.0: a major update of the phenol-explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database (Oxford), 2012.
62. Rothwell, J.-A., Perez-Jimenez, J., Neveu, V., Medina-Remon, A. et al., Phenol-explorer 3.0: a major update of the phenol-explorer database to incorporate data on the effects of food processing on polyphenol content. Database (Oxford), 2013.